Clinical Trials DEA Legalization THC 
The Cannigma
JUNE 14, 2021
All that is about to change, thanks to a change at the DEA , which cultivators and industry experts say will be monumental for cannabis research, medical marijuana patients, and potentially the broader legal status of the plant itself. “We Junk’ cannabis ‘ill-suited for clinical trials’. BRC) told The Cannigma this week.
Cannabis Law Report
NOVEMBER 4, 2021
It seems like every day I read a new story about legislators, high-ranking federal officials, and frustrated advocates of marijuana research complaining that researchers still can’t study the actual marijuana that people are using in the state-legal markets. Drug Enforcement Agency (DEA) to cultivate marijuana for research purposes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Veriheal
APRIL 11, 2022
He also emphasized the fact that medical cannabis programs are now legal in 37 states, as well as four out of five inhabited U.S. The company initiated the first legal transfer (as deemed by federal law) to the U.S. Drug Enforcement Agency (DEA). territories. What Cannabis-Based Medicines Have Been Approved So Far?
CannaMD
AUGUST 8, 2020
But CBD’s stolen the spotlight, partially because of its good cop/bad cop relationship with another famous cannabinoid: T etrahydrocannabinol or THC. THC is responsible for marijuana’s psychoactive effects. If you feel “high,” THC’s usually to blame. However, there are a number of restrictions.
MedicalJane
JUNE 29, 2018
percent of tetrahydrocannabinol (THC), the cannabinoid responsible for producing “high” psychoactive effects when consumed. Use of CBD in seizure prevention is well-documented with research ; and now, after conducting its own trials, the FDA appears to agree. Clinical trials show that Epidiolex significantly reduces seizure frequency.
SpeedWeed
MARCH 25, 2021
A long-awaited clinical trial on using cannabis as a treatment for veterans with PTSD has finally been published in the PLOS One journal , but the results are far less promising than researchers and veterans had hoped. million grant from the Multidisciplinary Association of Psychedelic Studies (MAPS). Each subject was asked to smoke 1.8
SpeedWeed
MARCH 18, 2021
One group self-administered cannabis with 12% THC over three weeks. Another group received an 11% CBD product with minimal THC. A third group received a balanced THC-CBD product, with roughly 8% THC and 8% CBD. for the production of cannabis used in federally-regulated clinical trials.
Expert insights. Personalized for you.
133 
Let's personalize your content